However, the results of this study show that increased plasma levels of sIL‐6R are associated with increased risk of glioma and the levels of sIL‐6R were constantly higher in cases than in controls, suggesting an aetiological role of sIL‐6R in glioma risk, especially for GBM. This evidence concerns the gene IL6R and glioblastoma.